Phosphatidylinositol 4-kinase as a target of pathogens-friend or foe?

Phosphatidylinositol 4-kinases (PI4Ks) are pivotal enzymes responsible for the generation of phosphatidylinositol 4-phosphate (PI4P), a key precursor involved in various cellular signalling pathways that regulate vesicular trafficking, Golgi maintenance and intracellular communication. Conserved across eukaryotic species, PI4Ks exist in distinct isoforms with specific localisations and functions, ranging from plasma membrane dynamics to endosomal trafficking and autophagy regulation. Notably, numerous pathogens, including viruses, bacteria and parasites, have evolved mechanisms to hijack host PI4Ks, thereby facilitating intracellular replication and survival. For example, RNA viruses within the Flaviviridae and Coronaviridae families recruit PI4Ks to remodel host membranes for the assembly of replication complexes. Similarly, intracellular bacteria such as Salmonella and Legionella manipulate PI4P-enriched compartments to evade host defences and promote replication. Due to their central roles in both normal cellular physiology and infection, PI4Ks have emerged as promising therapeutic targets. A variety of inhibitors, including ATP-competitive compounds, have been developed and evaluated for their antiviral, antibacterial and antiparasitic potential. Nevertheless, challenges related to selectivity and toxicity remain. Recent advances include the identification of inhibitors effective against Plasmodium species and the development of compounds targeting PI4KIIIβ in infections with viruses such as hepatitis C and coronaviruses. This review highlights the dual role of PI4Ks as essential cellular regulators and exploitable pathogen cofactors, underscoring their potential as drug targets. Continued investigation into the structure, function and inhibition of PI4Ks may enable the development of selective therapeutic strategies for infectious diseases while minimising off-target effects on host cells.

• Publication year

  2025

• Venue

  FEBS Letters

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1873-3468.70216PMID 41220232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting PI4KB and Src/Abl host kinases as broad-spectrum antiviral strategy: myth or real opportunity?

  2025cited by this paper
• The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4‐Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria

  2025cited by this paper
• ATG9A and ARFIP2 cooperate to control PI4P levels for lysosomal repair

  2025cited by this paper
• Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents.

  2024cited by this paper
• Inhibition of protein kinase D and its substrate phosphatidylinositol-4 kinase III beta blocks common human coronavirus replication

  2024cited by this paper
• Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis

  2024cited by this paper
• Comparative efficacy and safety of anti-cryptosporidial agents: an in vitro study on nitazoxanide, halofuginone lactate, KDU731, and paromomycin against Cryptosporidium parvum

  2024cited by this paper
• From the “One-Molecule, One-Target, One-Disease” Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections

  2024cited by this paper
• Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families.

  2024cited by this paper
• 2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy

  2024cited by this paper
• Nutrient-regulated control of lysosome function by signaling lipid conversion.

  2023cited by this paper
• Research progress on phosphatidylinositol 4-kinase inhibitors.

  2023cited by this paper
• Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana

  2023cited by this paper
• CUR-N399, a PI4KB inhibitor, for the treatment of Enterovirus A71 infection.

  2023cited by this paper
• Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds

  2023cited by this paper
• Efficacy of the Antimalarial MMV390048 against Babesia Infection Reveals Phosphatidylinositol 4-Kinase as a Druggable Target for Babesiosis

  2022cited by this paper
• Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells

  2022cited by this paper
• Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

  2022cited by this paper
• Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts

  2022cited by this paper
• A phosphoinositide signalling pathway mediates rapid lysosomal repair

  2022cited by this paper
• SAC1 regulates autophagosomal phosphatidylinositol-4-phosphate for xenophagy-directed bacterial clearance

  2021cited by this paper
• Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses

  2021cited by this paper
• Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells

  2021cited by this paper
• Microautophagy in the yeast vacuole depends on the activities of phosphatidylinositol 4-kinases, Stt4p and Pik1p.

  2020cited by this paper
• Essential and distinct roles of phosphatidylinositol 4-kinases, Pik1p and Stt4p, in yeast autophagy.

  2019cited by this paper
• Correction: VAPB depletion alters neuritogenesis and phosphoinositide balance in motoneuron-like cells: relevance to VAPB-linked amyotrophic lateral sclerosis (doi:10.1242/jcs.220061)

  2019cited by this paper
• Phosphoinositides: Regulators of Nervous System Function in Health and Disease

  2019cited by this paper
• SopF, a phosphoinositide binding effector, promotes the stability of the nascent Salmonella-containing vacuole

  2019cited by this paper
• Targeting host lipid flows: Exploring new antiviral and antibiotic strategies

  2019cited by this paper
• VAPB depletion alters neuritogenesis and phosphoinositide balance in motoneuron-like cells: relevance to VAPB-linked amyotrophic lateral sclerosis

  2019cited by this paper
• PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases

  2018cited by this paper
• RAB30 regulates PI4KB (phosphatidylinositol 4-kinase beta)-dependent autophagy against group A Streptococcus

  2018cited by this paper
• Plasmodial Kinase Inhibitors: License to Cure?

  2018cited by this paper
• PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells.

  2017cited by this paper
• A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

  2017cited by this paper
• Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

  2017cited by this paper
• The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites

  2017cited by this paper
• Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.

  2016cited by this paper
• The Salmonella effector SteA binds phosphatidylinositol 4‐phosphate for subcellular targeting within host cells

  2016cited by this paper
• Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium.

  2016cited by this paper
• Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in disease.

  2016cited by this paper
• Phosphatidylinositol 4-kinases: Function, structure, and inhibition.

  2015cited by this paper
• Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of Action.

  2015cited by this paper
• Pharmacological and Genetic Targeting of the PI4KA Enzyme Reveals Its Important Role in Maintaining Plasma Membrane Phosphatidylinositol 4-Phosphate and Phosphatidylinositol 4,5-Bisphosphate Levels*

  2014cited by this paper
• The crystal structure of the phosphatidylinositol 4‐kinase IIα

  2014cited by this paper
• Molecular insights into the membrane-associated phosphatidylinositol 4-kinase IIα

  2014cited by this paper
• Cinderella story: PI4P goes from precursor to key signaling molecule

  2014cited by this paper
• Targeting Plasmodium PI(4)K to eliminate malaria

  2013cited by this paper
• Multiple Classes of Antiviral Agents Exhibit In Vitro Activity against Human Rhinovirus Type C

  2013cited by this paper
• Targeting Plasmodium phosphatidylinositol 4-kinase to eliminate malaria

  2013cited by this paper
• Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.

  2013cited by this paper
• Phosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platforms

  2012cited by this paper
• Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication

  2012cited by this paper
• Phosphatidylinositol 4-Kinases Are Required for Autophagic Membrane Trafficking*

  2012cited by this paper
• Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity

  2012cited by this paper
• Entry of Listeria monocytogenes in mammalian epithelial cells: an updated view.

  2012cited by this paper
• Coordination of Golgi functions by phosphatidylinositol 4-kinases.

  2011cited by this paper
• Role of the Second Cysteine-rich Domain and Pro275 in Protein Kinase D2 Interaction with ADP-Ribosylation Factor 1, Trans-Golgi Network Recruitment, and Protein Transport

  2010cited by this paper
• Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication

  2010cited by this paper
• Multiple Host Proteins That Function in Phosphatidylinositol-4-Phosphate Metabolism Are Recruited to the Chlamydial Inclusion

  2010cited by this paper
• Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication

  2009cited by this paper
• The multiple roles of PtdIns(4)P – not just the precursor of PtdIns(4,5)P2

  2008cited by this paper
• Phosphatidylinositol 4-Kinase III-β Is Required for Golgi Maintenance and Cytokinesis in Trypanosoma brucei

  2007cited by this paper
• Phosphatidylinositol 4-kinases: old enzymes with emerging functions.

  2006cited by this paper
• A role for the RabA4b effector protein PI-4Kβ1 in polarized expansion of root hair cells in Arabidopsis thaliana

  2006cited by this paper
• Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex.

  2005cited by this paper
• Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex

  2005cited by this paper
• Phosphatidylinositol 4-kinasebeta is critical for functional association of rab11 with the Golgi complex.

  2004cited by this paper
• Getting to know protein kinase D.

  2002cited by this paper
• The Group-Specific Murine Coronavirus Genes Are Not Essential, but Their Deletion, by Reverse Genetics, Is Attenuating in the Natural Host

  2002cited by this paper
• Cloning and characterization of a human phosphatidylinositol 4-kinase.

  1994cited by this paper

• No citing papers are available for this paper.